CTOs on the Move

Perosphere Technologies

www.perospheretech.com

 
Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics and medical device based drug delivery systems.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Dental Health Alliance

Dental Health Alliance is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Windy City Cannabis

Windy City Cannabis is your Chicagoland dispensary. Visit our medical and recreational dispensary locations near you in Homewood, Justice, Posen and Worth.

Ratio Corp

Ratio Corp is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Bright Spot for Health

The Bright Spot for Health is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.